FDA has approved a new sleep drug, Dayvigo, 5 mg and 10 mg, based on two late-stage placeboe controlled studies for insomnia. Use for 1-6 months, to be classified as a controlled substance because it can be addictive and has the potential to be abused https://t.co/e2ZVWm39tN